Understanding the pharmacology of severe insomnia interventions requires a careful look at central nervous system depressants. Historically, short-acting barbiturates such as pentobarbital sodium, widely recognized under its commercial brand name Nembutal, were prominent solutions for intractable sleep disorders. Over the decades, medical protocols shifted toward modern non-barbiturate sedatives due to the narrow therapeutic index and […]